Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory S Matte

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Perfusion|June 20, 2022
Vein of Galen malformation and cardiopulmonary bypassGregory S Matte
Artificial Organs|November 30, 2018
Global outreach to improve the provision of cardiopulmonary bypass for patients with congenital heart diseaseGregory S Matte
The Journal of Extra-Corporeal Technology|October 13, 2016
It is Time to Update Membrane Oxygenator Testing Standards and Their Instructions for UseGregory S Matte
JTCVS Open|August 25, 2022
Commentary: Round and round the mesenchymal stromal cells go; where they stop, we hope to knowGregory S Matte, James A DiNardo
Artificial Organs|January 10, 2018
Translational Research: Comparing Oxygenators From Different International MarketsGregory S Matte, Rodolfo A Neirotti
The Journal of Extra-Corporeal Technology|December 4, 2012
History and use of del Nido cardioplegia solution at Boston Children's HospitalGregory S Matte, Pedro J del Nido
The Journal of Extra-Corporeal Technology|May 23, 2013
A single-center experience with luminal venous cannulae obstruction caused by clot formation during bypassGregory S Matte, Robert J Howe, Frank Pigula
The Journal of Extra-Corporeal Technology|May 3, 2016
Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device PlacementKatie H Faella, David Whiting, Francis Fynn-Thompson, et al.
Hospital Pharmacy|December 26, 2017
Production Standard and Stability of Compounded Del Nido Cardioplegia SolutionLuis M Pereira, Gregory S Matte, Peter Lutz, et al.
The Journal of Extra-Corporeal Technology|January 10, 2020
Transition from Hemochron Response to Hemochron Signature Elite Activated Clotting Time Devices in a Congenital Cardiac Surgery PracticeGregory S Matte, Robert J Howe, Juan Ibla, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Perfusion|June 20, 2022
Vein of Galen malformation and cardiopulmonary bypassGregory S Matte
Artificial Organs|November 30, 2018
Global outreach to improve the provision of cardiopulmonary bypass for patients with congenital heart diseaseGregory S Matte
The Journal of Extra-Corporeal Technology|October 13, 2016
It is Time to Update Membrane Oxygenator Testing Standards and Their Instructions for UseGregory S Matte
JTCVS Open|August 25, 2022
Commentary: Round and round the mesenchymal stromal cells go; where they stop, we hope to knowGregory S Matte, James A DiNardo
Artificial Organs|January 10, 2018
Translational Research: Comparing Oxygenators From Different International MarketsGregory S Matte, Rodolfo A Neirotti
The Journal of Extra-Corporeal Technology|December 4, 2012
History and use of del Nido cardioplegia solution at Boston Children's HospitalGregory S Matte, Pedro J del Nido
The Journal of Extra-Corporeal Technology|May 23, 2013
A single-center experience with luminal venous cannulae obstruction caused by clot formation during bypassGregory S Matte, Robert J Howe, Frank Pigula
The Journal of Extra-Corporeal Technology|May 3, 2016
Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device PlacementKatie H Faella, David Whiting, Francis Fynn-Thompson, et al.
Hospital Pharmacy|December 26, 2017
Production Standard and Stability of Compounded Del Nido Cardioplegia SolutionLuis M Pereira, Gregory S Matte, Peter Lutz, et al.
The Journal of Extra-Corporeal Technology|January 10, 2020
Transition from Hemochron Response to Hemochron Signature Elite Activated Clotting Time Devices in a Congenital Cardiac Surgery PracticeGregory S Matte, Robert J Howe, Juan Ibla, et al.
Pageof 4